Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno)benzoic acid potassium salt

P. Vernole, D. Caporossi, B. Tedeschi, G. Melino, B. Porfirio, E. Bonmassar, B. Nicoletti

Research output: Contribution to journalArticle


The 1-p-(3-methyltriazeno) benzoic acid potassium salt (MTBA) is a triazeno analogue of dacarbazine, an antineoplastic agent capable of mediating the appearance of new antigenic specificities on cancer cells in mice, a phenomenon described as 'chemical xenogenization' (CX). Recently we reported the clastogenic potential of MTBA on human lymphocytes. Since sister-chromatid exchange (SCE) assay is more sensitive than clastogenic tests, at least at low drug concentrations, we assessed SCE frequencies induced by MTBA on human lymphocytes stimulated by PHA. Drug treatment at 2-500 μg/ml was performed in vitro prior to or after PHA addition. SCE values increased significantly in a dose-dependent manner up to 200 μg/ml. However, SCE frequencies, as well as chromosome breaks, did not increase dramatically. These data indicate that MTBA concentrations used for CX do not cause severe cytogenetic damage to immune cells at least in vitro.

Original languageEnglish
Pages (from-to)233-236
Number of pages4
JournalMutation Research Letters
Issue number3-4
Publication statusPublished - 1988


  • 1-p-(3-Methyltriazeno) benzoic acid potassium salt
  • Human lymphocytes
  • Sister-chromatid exchanges

ASJC Scopus subject areas

  • Genetics
  • Toxicology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno)benzoic acid potassium salt'. Together they form a unique fingerprint.

  • Cite this